Nephrolithiasis

1. Khan SR, Pearle MS, Robertson WG, et al. Kidney stones. Nat Rev Dis Primers. 2016 Feb 25;2:16008.[Abstract][Full Text]

2. Eisner BH, Goldfarb DS, Baum MA, et al. Evaluation and medical management of patients with cystine nephrolithiasis: a consensus statement. J Endourol. 2020 Nov;34(11):1103-10.[Abstract][Full Text]

3. Scales CD Jr, Smith AC, Hanley JM, et al. Prevalence of kidney stones in the United States. Eur Urol. 2012 Jul;62(1):160-5.[Abstract][Full Text]

4. Sorokin I, Mamoulakis C, Miyazawa K, et al. Epidemiology of stone disease across the world. World J Urol. 2017 Sep;35(9):1301-20.[Abstract]

5. Liu Y, Chen Y, Liao B, et al. Epidemiology of urolithiasis in Asia. Asian J Urol. 2018 Oct;5(4):205-14.[Abstract][Full Text]

6. Tasian GE, Ross ME, Song L, et al. Annual incidence of nephrolithiasis among children and adults in South Carolina from 1997 to 2012. Clin J Am Soc Nephrol. 2016 Mar 7;11(3):488-96.[Abstract][Full Text]

7. Romero V, Akpinar H, Assimos DG. Kidney stones: a global picture of prevalence, incidence, and associated risk factors. Rev Urol. 2010 Spring;12(2-3):e86-96.[Abstract]

8. Fakheri RJ, Goldfarb DS. Ambient temperature as a contributor to kidney stone formation: implications of global warming. Kidney Int. 2011 Jun;79(11):1178-85.[Abstract][Full Text]

9. Liu J, Varghese BM, Hansen A, et al. Hot weather as a risk factor for kidney disease outcomes: a systematic review and meta-analysis of epidemiological evidence. Sci Total Environ. 2021 Dec 20;801:149806.[Abstract]

10. Curhan GC, Willett WC, Rimm EB, et al. Body size and risk of kidney stones. J Am Soc Nephrol. 1998 Sep;9(9):1645-52.[Abstract][Full Text]

11. Taylor EN, Stampfer MJ, Curhan GC. Obesity, weight gain, and the risk of kidney stones. JAMA. 2005 Jan 26;293(4):455-62.[Abstract][Full Text]

12. Aune D, Mahamat-Saleh Y, Norat T, et al. Body fatness, diabetes, physical activity and risk of kidney stones: a systematic review and meta-analysis of cohort studies. Eur J Epidemiol. 2018 Nov;33(11):1033-47.[Abstract][Full Text]

13. Worcester EM. Inhibitors of stone formation. Semin Nephrol. 1996;16:474-486.[Abstract]

14. Evan AP, Lingeman JE, Coe FL, et al. Randall's plaque of patients with nephrolithiasis begins in basement membranes of thin loops of Henle. J Clin Invest. 2003;111:607-616.[Abstract][Full Text]

15. Agarwal MM, Singh SK, Mavuduru R, et al. Preventive fluid and dietary therapy for urolithiasis: an appraisal of strength, controversies and lacunae of current literature. Indian J Urol. 2011 Jul;27(3):310-9.[Abstract][Full Text]

16. Borghi L, Meschi T, Schianchi T, et al. Urine volume: stone risk factor and preventive measure. Nephron. 1999;8(suppl 1):31-7.[Abstract]

17. Pearle MS, Goldfarb DS, Assimos DG, et al. Medical management of kidney stones: AUA guideline. J Urol. 2014 Aug;192(2):316-24.[Abstract][Full Text]

18. Cheungpasitporn W, Rossetti S, Friend K, et al. Treatment effect, adherence, and safety of high fluid intake for the prevention of incident and recurrent kidney stones: a systematic review and meta-analysis. J Nephrol. 2016 Apr;29(2):211-9.[Abstract][Full Text]

19. Bao Y, Tu X, Wei Q. Water for preventing urinary stones. Cochrane Database Syst Rev. 2020 Feb 11;2:CD004292.[Abstract][Full Text]

20. Curhan GC, Willett WC, Rimm EB, et al. A prospective study of dietary calcium and other nutrients and the risk of symptomatic kidney stones. N Engl J Med. 1993 Mar 25;328(12):833-8.[Abstract][Full Text]

21. Curhan GC, Willett WC, Speizer FE, et al. Comparison of dietary calcium with supplemental calcium and other nutrients as factors affecting the risk for kidney stones in women. Ann Intern Med. 1997 Apr 1;126(7):497-504.[Abstract]

22. Sakhaee K, Harvey JA, Padalino PK, et al. The potential role of salt abuse on the risk for kidney stone formation. J Urol. 1993 Aug;150(2 pt 1):310-2.[Abstract]

23. Soucie JM, Thun MJ, Coates RJ, et al. Demographic and geographic variability of kidney stones in the United States. Kidney Int. 1994 Sep;46(3):893-9.[Abstract]

24. Sarmina I, Spirnak JP, Resnick MI. Urinary lithiasis in the black population: an epidemiological study and review of the literature. J Urol. 1987 Jul;138(1):14-7.[Abstract]

25. Hiatt RA, Dales LG, Friedman GD, et al. Frequency of urolithiasis in a prepaid medical care program. Am J Epidemiol. 1982 Feb;115(2):255-65.[Abstract]

26. Stamatelou KK, Francis ME, Jones CA, et al. Time trends in reported prevalence of kidney stones in the United States: 1976-1994. Kidney Int. 2003 May;63(5):1817-23.[Abstract]

27. Perletti G, Magri V, Ferraro PM, et al. Influence of dietary energy intake on nephrolithiasis - a meta-analysis of observational studies. Arch Ital Urol Androl. 2020 Apr 6;92(1):30-3.[Abstract][Full Text]

28. Rahman IA, Nusaly IF, Syahrir S, et al. Association between metabolic syndrome components and the risk of developing nephrolithiasis: a systematic review and bayesian meta-analysis. F1000Res. 2021;10:104.[Abstract][Full Text]

29. Geraghty R, Abdi A, Somani B, et al. Does chronic hyperglycaemia increase the risk of kidney stone disease? results from a systematic review and meta-analysis. BMJ Open. 2020 Jan 19;10(1):e032094.[Abstract][Full Text]

30. Wijarnpreecha K, Lou S, Panjawatanan P, et al. Nonalcoholic fatty liver disease and urolithiasis: a systematic review and meta-analysis. J Gastrointestin Liver Dis. 2018 Dec;27(4):427-32.[Abstract]

31. Jung H, Andonian S, Assimos D, et al. Urolithiasis: evaluation, dietary factors, and medical management: an update of the 2014 SIU-ICUD international consultation on stone disease. World J Urol. 2017 Sep;35(9):1331-40.[Abstract]

32. Gadiyar N, Geraghty RM, Premakumar Y, et al. Changes in urine composition and risk of kidney stone disease following bariatric surgery: a systematic review over last 2 decades. Curr Urol Rep. 2022 Nov;23(11):279-95.[Abstract]

33. Premakumar Y, Gadiyar N, Hameed BMZ, et al. Association of kidney stone disease (KSD) with primary gastrointestinal surgery: a systematic review over last 2 decades. Curr Urol Rep. 2021 May 24;22(6):34.[Abstract][Full Text]

34. Geraghty RM, Proietti S, Traxer O, et al. Worldwide impact of warmer seasons on the incidence of renal colic and kidney stone disease: evidence from a systematic review of literature. J Endourol. 2017 Aug;31(8):729-35.[Abstract]

35. Zhang Y, Long G, Ding B, et al. The impact of ambient temperature on the incidence of urolithiasis: a systematic review and meta-analysis. Scand J Work Environ Health. 2020 Mar 1;46(2):117-26.[Abstract][Full Text]

36. Policastro LJ, Saggi SJ, Goldfarb DS, et al. Personalized intervention in monogenic stone formers. J Urol. 2018 Mar;199(3):623-32.[Abstract][Full Text]

37. Atmoko W, Raharja PAR, Birowo P, et al. Genetic polymorphisms as prognostic factors for recurrent kidney stones: a systematic review and meta-analysis. PLoS One. 2021 May 6;16(5):e0251235.[Abstract][Full Text]

38. Daudon M, Frochot V, Bazin D, et al. Drug-induced kidney stones and crystalline nephropathy: pathophysiology, prevention and treatment. Drugs. 2018 Feb;78(2):163-201.[Abstract]

39. Tasian GE, Jemielita T, Goldfarb DS, et al. Oral antibiotic exposure and kidney stone disease. J Am Soc Nephrol. 2018 Jun;29(6):1731-40.[Abstract]

40. Asoudeh F, Talebi S, Jayedi A, et al. Associations of total protein or animal protein intake and animal protein sources with risk of kidney stones: a systematic review and dose-response meta-analysis. Adv Nutr. 2022 Jun 1;13(3):821-32.[Abstract][Full Text]

41. Borghi L, Schianchi T, Meschi T, et al. Comparison of two diets for the prevention of recurrent stones in idiopathic hypercalciuria. N Engl J Med. 2002 Jan 10;346(2):77-84.[Abstract][Full Text]

42. Ferraro PM, Mandel EI, Curhan GC, et al. Dietary protein and potassium, diet-dependent net acid load, and risk of incident kidney stones. Clin J Am Soc Nephrol. 2016 Oct 7;11(10):1834-44.[Abstract][Full Text]

43. Dai JC, Pearle MS. Diet and stone disease in 2022. J Clin Med. 2022 Aug 13;11(16):4740.[Abstract][Full Text]

44. Jiang K, Tang K, Liu H, et al. Ascorbic Acid supplements and kidney stones incidence among men and women: a systematic review and meta-analysis. Urol J. 2019 May 5;16(2):115-20.[Abstract][Full Text]

45. Thomas LD, Elinder CG, Tiselius HG, et al. Ascorbic acid supplements and kidney stone incidence among men: a prospective study. JAMA Intern Med. 2013 Mar 11;173(5):386-8.[Abstract]

46. Lin BB, Lin ME, Huang RH, et al. Dietary and lifestyle factors for primary prevention of nephrolithiasis: a systematic review and meta-analysis. BMC Nephrol. 2020 Jul 11;21(1):267.[Abstract][Full Text]

47. Wang Z, Zhang Y, Wei W. Effect of dietary treatment and fluid intake on the prevention of recurrent calcium stones and changes in urine composition: a meta-analysis and systematic review. PLoS One. 2021;16(4):e0250257.[Abstract][Full Text]

48. European Association of Urology. Urolithiasis. Mar 2023 [internet publication].[Full Text]

49. Minotti B, Treglia G, Pascale M, et al. Prevalence of microhematuria in renal colic and urolithiasis: a systematic review and meta-analysis. BMC Urol. 2020 Aug 8;20(1):119.[Abstract][Full Text]

50. Mefford JM, Tungate RM, Amini L, et al. A comparison of urolithiasis in the presence and absence of microscopic hematuria in the emergency department. West J Emerg Med. 2017 Jun;18(4):775-9.[Abstract][Full Text]

51. Ganesan C, Weia B, Thomas IC, et al. Analysis of primary hyperparathyroidism screening among US veterans with kidney stones. JAMA Surg. 2020 Sep 1;155(9):861-8.[Abstract][Full Text]

52. American College of Radiology. ACR appropriateness criteria: acute onset flank pain-suspicion of stone disease (urolithiasis). 2023 [internet publication].[Full Text]

53. Fulgham PF, Assimos DG, Pearle MS, et al. Clinical effectiveness protocols for imaging in the management of ureteral calculous disease: AUA Technology Assessment. J Urol. 2013 Apr;189(4):1203-13.[Abstract][Full Text]

54. Ripollés T, Agramunt M, Errando J, et al. Suspected ureteral colic: plain film and sonography vs unenhanced helical CT. A prospective study in 66 patients. Eur Radiol. 2004 Jan;14(1):129-36.[Abstract]

55. Gorelik U, Ulish Y, Yagil Y. The use of standard imaging techniques and their diagnostic value in the workup of renal colic in the setting of intractable flank pain. Urology. 1996 May;47(5):637-42.[Abstract]

56. Dalla Palma L, Stacul F, Bazzocchi M, et al. Ultrasonography and plain film versus intravenous urography in ureteric colic. Clin Radiol. 1993 May;47(5):333-6.[Abstract]

57. Smith-Bindman R, Aubin C, Bailitz J, et al. Ultrasonography versus computed tomography for suspected nephrolithiasis. N Engl J Med. 2014 Sep 18;371(12):1100-10.[Abstract][Full Text]

58. Metzler IS, Smith-Bindman R, Moghadassi M, et al. Emergency department imaging modality effect on surgical management of nephrolithiasis: a multicenter, randomized clinical trial. J Urol. 2017 Mar;197(3 pt 1):710-4.[Abstract][Full Text]

59. Wong C, Teitge B, Ross M, et al. The accuracy and prognostic value of point-of-care ultrasound for nephrolithiasis in the emergency department: a systematic review and meta-analysis. Acad Emerg Med. 2018 Jun;25(6):684-98.[Abstract][Full Text]

60. ACOG Committee on Obstetric Practice. Committee opinion no. 723: Guidelines for diagnostic imaging during pregnancy and lactation. Obstet Gynecol. 2017 Oct;130(4):e210-6.[Abstract][Full Text]

61. Valovska MI, Pais VM Jr. Contemporary best practice urolithiasis in pregnancy. Ther Adv Urol. 2018 Apr;10(4):127-38.[Abstract][Full Text]

62. Grivas N, Thomas K, Drake T, et al. Imaging modalities and treatment of paediatric upper tract urolithiasis: a systematic review and update on behalf of the EAU urolithiasis guidelines panel. J Pediatr Urol. 2020 Oct;16(5):612-24.[Abstract]

63. McGrath TA, Frank RA, Schieda N, et al. Diagnostic accuracy of dual-energy computed tomography (DECT) to differentiate uric acid from non-uric acid calculi: systematic review and meta-analysis. Eur Radiol. 2020 May;30(5):2791-801.[Abstract]

64. Worcester EM, Coe FL. Clinical practice. Calcium kidney stones. N Engl J Med. 2010 Sep 2;363(10):954-63.[Abstract][Full Text]

65. Uribarri J, Oh MS, Carroll HJ. The first kidney stone. Ann Intern Med. 1989 Dec 15;111(12):1006-9.[Abstract]

66. Moore CL, Daniels B, Ghita M, et al. Accuracy of reduced-dose computed tomography for ureteral stones in emergency department patients. Ann Emerg Med. 2015 Feb;65(2):189-98.[Abstract][Full Text]

67. American Urological Association. Microhematuria: AUA/SUFU guideline. 2020 [internet publication].[Full Text]

68. American College of Radiology. ACR Appropriateness Criteria: hematuria. 2019 [internet publication].[Full Text]

69. American College of Radiology. ACR Appropriateness Criteria: hematuria - child. 2018 [internet publication].[Full Text]

70. American College of Radiology. ACR Appropriateness Criteria: acute nonlocalized abdominal pain. 2018 [internet publication].[Full Text]

71. Assimos D, Krambeck A, Miller NL, et al. Surgical management of stones: American Urological Association/Endourological Society Guideline. 2016 [internet publication].[Full Text]

72. Canadian Urological Association. Evaluation and medical management of kidney stones​. Jun 2022 [internet publication].[Full Text]

73. Sammon JD, Ghani KR, Karakiewicz PI, et al. Temporal trends, practice patterns, and treatment outcomes for infected upper urinary tract stones in the United States. Eur Urol. 2013 Jul;64(1):85-92.[Abstract]

74. Dreger NM, Degener S, Ahmad-Nejad P, et al. Urosepsis--etiology, diagnosis, and treatment. Dtsch Arztebl Int. 2015 Dec 4;112(49):837-47.[Abstract][Full Text]

75. Pathan SA, Mitra B, Cameron PA. A systematic review and meta-analysis comparing the efficacy of nonsteroidal anti-inflammatory drugs, opioids, and paracetamol in the treatment of acute renal colic. Eur Urol. 2018 Apr;73(4):583-95.[Abstract]

76. Afshar K, Jafari S, Marks AJ, et al. Nonsteroidal anti-inflammatory drugs (NSAIDs) and non-opioids for acute renal colic. Cochrane Database Syst Rev. 2015 Jun 29;(6):CD006027.[Abstract][Full Text]

77. National Institute for Health and Care Excellence. Renal and ureteric stones: assessment and management. Jan 2019 [internet publication].[Full Text]

78. Davenport K, Waine E. The role of non-steroidal anti-inflammatory drugs in renal colic. Pharmaceuticals (Basel). 2010 Apr 28;3(5):1304-10.[Abstract][Full Text]

79. Gu HY, Luo J, Wu JY, et al. Increasing nonsteroidal anti-inflammatory drugs and reducing opioids or paracetamol in the management of acute renal colic: based on three-stage study design of network meta-analysis of randomized controlled trials. Front Pharmacol. 2019;10:96.[Abstract][Full Text]

80. Fakhr Yasseri A, Saatchi M, Khatami F, et al. The prevalence of renal stones and outcomes of conservative treatment in kidney transplantation: a systematic review and meta-analysis. Urol J. 2021 May 8;18(3):252-8.[Abstract][Full Text]

81. Jendeberg J, Geijer H, Alshamari M, et al. Size matters: the width and location of a ureteral stone accurately predict the chance of spontaneous passage. Eur Radiol. 2017 Nov;27(11):4775-85.[Abstract][Full Text]

82. Eisner BH, Goldfarb DS, Pareek G. Pharmacologic treatment of kidney stone disease. Urol Clin North Am. 2013 Feb;40(1):21-30.[Abstract]

83. Campschroer T, Zhu X, Vernooij RW, et al. Alpha-blockers as medical expulsive therapy for ureteral stones. Cochrane Database Syst Rev. 2018;(4):CD008509.[Abstract][Full Text]

84. Sridharan K, Sivaramakrishnan G. Efficacy and safety of alpha blockers in medical expulsive therapy for ureteral stones: a mixed treatment network meta-analysis and trial sequential analysis of randomized controlled clinical trials. Expert Rev Clin Pharmacol. 2018 Mar;11(3):291-307.[Abstract]

85. Meltzer AC, Burrows PK, Wolfson AB, et al. Effect of tamsulosin on passage of symptomatic ureteral stones: a randomized clinical trial. JAMA Intern Med. 2018 Aug 1;178(8):1051-7.[Abstract][Full Text]

86. Hollingsworth JM, Canales BK, Rogers MA, et al. Alpha blockers for treatment of ureteric stones: systematic review and meta-analysis. BMJ. 2016 Dec 1;355:i6112.[Abstract][Full Text]

87. Wang RC, Smith-Bindman R, Whitaker E, et al. Effect of tamsulosin on stone passage for ureteral stones: a systematic review and meta-analysis. Ann Emerg Med. 2017 Mar;69(3):353-61.e3.[Abstract]

88. Aboumarzouk OM, Jones P, Amer T, et al. What is the role of alpha-blockers for medical expulsive therapy? Results rrom a meta-analysis of 60 randomized trials and over 9500 patients. Urology. 2018 Sep;119:5-16.[Abstract][Full Text]

89. Hsu YP, Hsu CW, Bai CH, et al. Silodosin versus tamsulosin for medical expulsive treatment of ureteral stones: aA systematic review and meta-analysis. PLoS One. 2018;13(8):e0203035.[Abstract][Full Text]

90. Oestreich MC, Vernooij RW, Sathianathen NJ, et al. Alpha-blockers after shock wave lithotripsy for renal or ureteral stones in adults. Cochrane Database Syst Rev. 2020 Nov 12;(11):CD013393.[Abstract][Full Text]

91. Micali S, Grande M, Sighinolfi MC, et al. Medical therapy of urolithiasis. J Endourol. 2006 Nov;20(11):841-7.[Abstract]

92. Lingeman JE, Matlaga BR, Evan AP. Surgical management of upper urinary tract calculi. In: Wein AJ, Kavoussi LR, Novick AC, et al., eds. Campbell's urology. 9th ed. Philadelphia, PA: Saunders Elsevier; 2007:1431-507.

93. Mantica G, Balzarini F, Chierigo F, et al. The fight between PCNL, laparoscopic and robotic pyelolithotomy: do we have a winner? A systematic review and meta-analysis. Minerva Urol Nephrol. 2022 Apr;74(2):169-77.[Abstract][Full Text]

94. Geraghty R, Burr J, Simmonds N, et al. Shock wave lithotripsy outcomes for lower pole and non-lower pole stones from a university teaching hospital: parallel group comparison during the same time period. Urol Ann. 2015 Jan-Mar;7(1):46-8.[Abstract][Full Text]

95. Junbo L, Yugen L, Guo J, et al. Retrograde intrarenal surgery vs. percutaneous nephrolithotomy vs. extracorporeal shock wave lithotripsy for lower pole renal stones 10-20 mm : a meta-analysis and systematic review. Urol J. 2019 May 5;16(2):97-106.[Abstract][Full Text]

96. Bozzini G, Verze P, Arcaniolo D, et al. A prospective randomized comparison among SWL, PCNL and RIRS for lower calyceal stones less than 2 cm: a multicenter experience : a better understanding on the treatment options for lower pole stones. World J Urol. 2017 Dec;35(12):1967-75.[Abstract]

97. Kachel TA, Vijan SR, Dretler SP. Endourological experience with cystine calculi and a treatment algorithm. J Urol. 1991 Jan;145(1):25-8.[Abstract]

98. Grasso M, Ficazzola M. Retrograde ureteropyeloscopy for lower pole caliceal calculi. J Urol. 1999 Dec;162(6):1904-8.[Abstract]

99. Aboumarzouk OM, Monga M, Kata SG, et al. Flexible ureteroscopy and laser lithotripsy for stones >2 cm: a systematic review and meta-analysis. J Endourol. 2012 Oct;26(10):1257-63.[Abstract]

100. Barone B, Crocetto F, Vitale R, et al. Retrograde intra renal surgery versus percutaneous nephrolithotomy for renal stones >2 cm. A systematic review and meta-analysis. Minerva Urol Nefrol. 2020 Aug;72(4):441-50.[Abstract][Full Text]

101. Soderberg L, Ergun O, Ding M, et al. Percutaneous nephrolithotomy versus retrograde intrarenal surgery for treatment of renal stones in adults. Cochrane Database Syst Rev. 2023 Nov 13;(11):CD013445.[Abstract]

102. Ordonez M, Hwang EC, Borofsky M, et al. Ureteral stent versus no ureteral stent for ureteroscopy in the management of renal and ureteral calculi. Cochrane Database Syst Rev. 2019 Feb 6;2:CD012703.[Abstract][Full Text]

103. Zhu Y, Duijvesz D, Rovers MM, et al. Alpha-blockers to assist stone clearance after extracorporeal shock wave lithotripsy: a meta-analysis. BJU Int. 2010 Jul;106(2):256-61.[Abstract]

104. Wang Z, Bai Y, Wang J. Effects of diuretic administration on outcomes of extracorporeal shockwave lithotripsy: a systematic review and meta-analysis. PLoS One. 2020 Mar 5;15(3):e0230059.[Abstract][Full Text]

105. Liu LR, Li QJ, Wei Q, et al. Percussion, diuresis, and inversion therapy for the passage of lower pole kidney stones following shock wave lithotripsy. Cochrane Database Syst Rev. 2013;(12):CD008569.[Abstract][Full Text]

106. Dong L, Wang F, Chen H, et al. The efficacy and safety of diuretics on extracorporeal shockwave lithotripsy treatment of urolithiasis: A systematic review and meta analysis. Medicine (Baltimore). 2020 Jun 19;99(25):e20602.[Abstract][Full Text]

107. Reynolds LF, Kroczak T, Pace KT. Indications and contraindications for shock wave lithotripsy and how to improve outcomes. Asian J Urol. 2018 Oct;5(4):256-63.[Abstract][Full Text]

108. Davis NF, Quinlan MR, Browne C, et al. Single-use flexible ureteropyeloscopy: a systematic review. World J Urol. 2018 Apr;36(4):529-36.[Abstract][Full Text]

109. Fahmy O, Shsm H, Lee C, et al. Impact of preoperative stenting on the outcome of flexible ureterorenoscopy for upper urinary tract urolithiasis: a systematic review and meta-analysis. Urol Int. 2022;106(7):679-87.[Abstract]

110. Chen H, Pan Y, Xiao M, et al. The outcomes of pre-stenting on renal and ureteral stones: a meta-analysis. Urol Int. 2022;106(5):495-503.[Abstract]

111. Law YXT, Teoh JYC, Castellani D, et al. Role of pre-operative ureteral stent on outcomes of retrograde intra-renal surgery (RIRS): systematic review and meta-analysis of 3831 patients and comparison of Asian and non-Asian cohorts. World J Urol. 2022 Jun;40(6):1377-89.[Abstract]

112. Dell'Atti L, Papa S. Ten-year experience in the management of distal ureteral stones greater than 10 mm in size. G Chir. 2016 Jan-Feb;37(1):27-30.[Abstract][Full Text]

113. Cui X, Ji F, Yan H, et al. Comparison between extracorporeal shock wave lithotripsy and ureteroscopic lithotripsy for treating large proximal ureteral stones: a meta-analysis. Urology. 2015 Apr;85(4):748-56.[Abstract]

114. Drake T, Grivas N, Dabestani S, et al. What are the benefits and harms of ureteroscopy compared with shock-wave lithotripsy in the treatment of upper ureteral stones? A systematic review. Eur Urol. 2017 Nov;72(5):772-86.[Abstract]

115. Aboumarzouk OM, Kata SG, Keeley FX, et al. Extracorporeal shock wave lithotripsy (ESWL) versus ureteroscopic management for ureteric calculi. Cochrane Database Syst Rev. 2012;(5):CD006029.[Abstract][Full Text]

116. Maheshwari PN, Oswal AT, Andankar M, et al. Is antegrade ureteroscopy better than retrograde ureteroscopy for impacted large upper ureteral calculi? J Endourol. 1999 Jul-Aug;13(6):441-4.[Abstract]

117. el-Nahas AR, Eraky I, el-Assmy AM, et al. Percutaneous treatment of large upper tract stones after urinary diversion. Urology. 2006 Sep;68(3):500-4.[Abstract]

118. Wang Q, Guo J, Hu H, et al. Rigid ureteroscopic lithotripsy versus percutaneous nephrolithotomy for large proximal ureteral stones: a meta-analysis. PLoS One. 2017 Feb 9;12(2):e0171478.[Abstract][Full Text]

119. Zeng G, Zhong W, Pearle M, et al. European Association of Urology Section of Urolithiasis and International Alliance of Urolithiasis Joint Consensus on percutaneous nephrolithotomy. Eur Urol Focus. 2022 Mar;8(2):588-97.[Abstract]

120. Breda A, Territo A, Scoffone C, et al. The evaluation of radiologic methods for access guidance in percutaneous nephrolithotomy: a systematic review of the literature. Scand J Urol. 2018 Apr;52(2):81-6.[Abstract][Full Text]

121. Lingeman JE, Coury TA, Newman DM, et al. Comparison of results and morbidity of percutaneous nephrostolithotomy and extracorporeal shock wave lithotripsy. J Urol. 1987 Sep;138(3):485-90.[Abstract]

122. Dorantes-Carrillo LA, Basulto-Martínez M, Suárez-Ibarrola R, et al. Retrograde intrarenal surgery versus miniaturized percutaneous nephrolithotomy for kidney stones >1cm: a systematic review and meta-analysis of randomized trials. Eur Urol Focus. 2022 Jan;8(1):259-70.[Abstract]

123. Zhang B, Hu Y, Gao J, et al. Micropercutaneous versus retrograde intrarenal surgery for the management of moderately sized kidney stones: a systematic review and meta-analysis. Urol Int. 2020;104(1-2):94-105.[Abstract]

124. Güler A, Erbin A, Ucpinar B, et al. Comparison of miniaturized percutaneous nephrolithotomy and standard percutaneous nephrolithotomy for the treatment of large kidney stones: a randomized prospective study. Urolithiasis. 2019 Jun;47(3):289-95.[Abstract]

125. Kandemir E, Savun M, Sezer A, et al. Comparison of miniaturized percutaneous nephrolithotomy and standard percutaneous nephrolithotomy in secondary patients: a randomized prospective study. J Endourol. 2020 Jan;34(1):26-32.[Abstract]

126. Feng D, Hu X, Tang Y, et al. The efficacy and safety of miniaturized percutaneous nephrolithotomy versus standard percutaneous nephrolithotomy: a systematic review and meta-analysis of randomized controlled trials. Investig Clin Urol. 2020 Mar;61(2):115-26.[Abstract][Full Text]

127. Semins MJ, Matlaga BR. Kidney stones during pregnancy. Nat Rev Urol. 2014 Mar;11(3):163-8.[Abstract]

128. Burgess KL, Gettman MT, Rangel LJ, et al. Diagnosis of urolithiasis and rate of spontaneous passage during pregnancy. J Urol. 2011 Dec;186(6):2280-4.[Abstract]

129. Zhou Q, Chen WQ, Xie XS, et al. Maternal and neonatal outcomes of pregnancy complicated by urolithiasis: a systematic review and meta-analysis. J Nephrol. 2021 Oct;34(5):1569-80.[Abstract]

130. Semins MJ, Trock BJ, Matlaga BR. The safety of ureteroscopy during pregnancy: a systematic review and meta-analysis. J Urol. 2009 Jan;181(1):139-43.[Abstract]

131. Gambaro G, Croppi E, Coe F, et al; Consensus Conference Group. Metabolic diagnosis and medical prevention of calcium nephrolithiasis and its systemic manifestations: a consensus statement. J Nephrol. 2016 Dec;29(6):715-34.[Abstract][Full Text]

132. US Food and Drug Administration. FDA adds Boxed Warning for increased risk of death with gout medicine Uloric (febuxostat). 21 February 2019 [internet publication].[Full Text]

133. White WB, Saag KG, Becker MA, et al. Cardiovascular safety of febuxostat or allopurinol in patients with gout. N Engl J Med. 2018 Mar 12;378(13):1200-10.[Abstract][Full Text]

134. Medicines and Healthcare products Regulatory Agency. Febuxostat (Adenuric): increased risk of cardiovascular death and all-cause mortality in clinical trial in patients with a history of major cardiovascular disease. July 2019 [internet publication].[Full Text]

135. Phillips R, Hanchanale VS, Myatt A, et al. Citrate salts for preventing and treating calcium containing kidney stones in adults. Cochrane Database Syst Rev. 2015;(10):CD010057.[Abstract][Full Text]

136. Kern A, Grimsby G, Mayo H, et al. Medical and dietary interventions for preventing recurrent urinary stones in children. Cochrane Database Syst Rev. 2017;(11):CD011252.[Abstract][Full Text]

137. Barreto L, Jung JH, Abdelrahim A, et al. Medical and surgical interventions for the treatment of urinary stones in children. Cochrane Database Syst Rev. 2019 Oct 9;10:CD010784.[Abstract][Full Text]

138. El Said NO, El Wakeel L, Kamal KM, et al. Alfuzosin treatment improves the rate and time for stone expulsion in patients with distal uretral stones: a prospective randomized controlled study. Pharmacotherapy. 2015 May;35(5):470-6.[Abstract]

139. Sur RL, Shore N, L'Esperance J. Silodosin to facilitate passage of ureteral stones: a multi-institutional, randomized, double-blinded, placebo-controlled trial. Eur Urol. 2015 May;67(5):959-64.[Abstract]

140. Yang D, Wu J, Yuan H, et al. The efficacy and safety of silodosin for the treatment of ureteral stones: a systematic review and meta-analysis. BMC Urol. 2016 May 27;16(1):23.[Abstract][Full Text]

141. Escribano J, Balaguer A, Roqué i Figuls M, et al. Dietary interventions for preventing complications in idiopathic hypercalciuria. Cochrane Database Syst Rev. 2014;(2):CD006022.[Abstract][Full Text]

142. Goldfarb DS, MacDonald PA, Gunawardhana L, et al. Randomized controlled trial of febuxostat versus allopurinol or placebo in individuals with higher urinary uric acid excretion and calcium stones. Clin J Am Soc Nephrol. 2013 Nov;8(11):1960-7.[Abstract][Full Text]

143. Worcester EM. Stones from bowel disease. Endocrinol Metab Clin North Am. 2002 Dec;31(4):979-99.[Abstract]

144. Pak CY, Fuller C, Sakhaee K, et al. Management of cystine nephrolithiasis with alpha-mercaptopropionylglycine. J Urol. 1986 Nov;136(5):1003-8.[Abstract]

145. Harper JD, Lingeman JE, Sweet RM, et al. Fragmentation of stones by burst wave lithotripsy in the first 19 humans. J Urol. 2022 May;207(5):1067-76.[Abstract][Full Text]

146. Razi A, Farrokhi E, Lotfabadi P, et al. Dexamethasone and ketorolac compare with ketorolac alone in acute renal colic: a randomized clinical trial. Am J Emerg Med. 2022 Aug;58:245-50.[Abstract]

147. Garrelfs SF, Frishberg Y, Hulton SA, et al. Lumasiran, an RNAi therapeutic for primary hyperoxaluria type 1. N Engl J Med. 2021 Apr 1;384(13):1216-26.[Abstract][Full Text]

148. American College of Radiology. ACR appropriateness criteria: radiologic management of urinary tract obstruction. 2019 [internet publication].[Full Text]

149. Canadian Urological Association. Management of ureteral calculi. Dec 2021 [internet publication].[Full Text]

150. Qaseem A, Dallas P, Forciea MA, et al. Dietary and pharmacologic management to prevent recurrent nephrolithiasis in adults: a clinical practice guideline from the American College of Physicians. Ann Intern Med. 2014 Nov 4;161(9):659-67.[Abstract][Full Text]

151. Brain E, Geraghty RM, Lovegrove CE, et al. Natural history of post-treatment kidney stone fragments: a systematic review and meta-analysis. J Urol. 2021 Sep;206(3):526-38.[Abstract][Full Text]

152. Rule AD, Lieske JC, Li X, et al. The ROKS nomogram for predicting a second symptomatic stone episode. J Am Soc Nephrol. 2014;25:2878-2886.[Abstract]

153. Moore SL, Cook P, de Coninck V, et al. Outcomes and long-term follow-up of patients with cystine stones: a systematic review. Curr Urol Rep. 2019 Apr 15;20(6):27.[Abstract]